The GlaxoSmithKline and Celgene-backed immunotherapy developer has floated in the middle of its range on the Nasdaq Global Market.

University of Ulm spinout WITec has agreed to a $50m acquisition by Oxford Instruments, itself the first-ever spinout of University of Oxford.

The oncology therapeutics developer has added $66m to its coffers thanks to investors including Berkeley Catalyst Fund.

Flagship Pioneering has re-opened its Fund VII to raise an additional $2.23bn that brought the vehicle’s total capital to $3.37bn.

The Industrial Biotechnology Innovation Centre will invest in research projects at Scottish universities to support the creation of more spinouts.

Alexandria Venture Investments was among the participants in a series A for the cellular cancer therapeutics developer based on work at Institut Curie and Memorial Sloan Kettering.

Alexandria Venture Investments was among the participants in a series A round for the cellular cancer therapeutics developer.

Limited partners including Alexandria Venture Investments and Royal Bank of Canada backed the healthcare technology-focused firm's first fund.

11Street and CJ Group contributed to a $71.8m round for on-demand logistics provider Barogo while Eli Lilly helped provide $66m for macrocycle drug developer Circle Pharma.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.